Prospective assessment of proliferative diabetic retinopathy with observations of posterior vitreous detachment

被引:36
|
作者
Ono R. [1 ]
Kakehashi A. [1 ]
Yamagami H. [1 ]
Sugi N. [1 ]
Kinoshita N. [1 ]
Saito T. [2 ]
Tamemoto H. [2 ]
Kuroki M. [2 ]
lshikawa S.-E. [2 ]
Kawakami M. [2 ]
机构
[1] Department of Ophthalmology, Jichi Medical University, Omiya Medical Center, Omiya-ku, Saitama 330-8503
[2] Department of Integrated Medicine 1, Jichi Medical University, Omiya Medical Center, Omiya-ku Saitama 330-8503
关键词
Diabetes; Diabetic retinopathy; HbA[!sub]1c[!/sub; Posterior vitreous detachment;
D O I
10.1007/s10792-005-5389-2
中图分类号
学科分类号
摘要
Purpose: To study the relation between posterior vitreous detachment (PVD) and progression of diabetic retinopathy (DR), based on our observation that proliferative DR is rare in patients with complete PVD. Methods: The medical records of 403 patients with diabetes were reviewed for the relation between progressive DR and the status of PVD and HbA1c over 3 years. PVD was classified into none, complete PVD with collapse, complete PVD without collapse, partial PVD with a thickened posterior vitreous cortex, and partial PVD without a thickened posterior vitreous cortex. DR was classified into none, simple, preproliferative, or proliferative. When it became more extensive or when laser treatment or vitreous surgery was performed, the DR was considered progressive. Results: Progression of DR over 3 years occurred in 128/292 (43.8%) eyes with no PVD, 0/14 (0%) eyes with complete PVD with collapse, 2/8 (25%) eyes with complete PVD without collapse, 15/15 (100%) eyes with partial PVD with a thickened posterior vitreous cortex, and 19/74 (25.7%) eyes with partial PVD without a thickened posterior vitreous cortex. Progression of DR occurred significantly more frequently in eyes with partial PVD with a thickened posterior vitreous cortex compared to eyes with complete PVD with collapse (p <0.0001). HbA1c, did not differ significantly between these two groups (6.9 ± 0.9% and 7.5 ± 0.9%, respectively; p = 0.14), although HbA1c was significantly higher (p = 0.04) in patients with progressive DR (78 ± 1.8%) than in patients without progressive DR (7.5 ± 1.5%). Conclusion: Complete PVD is a strong negative risk factor for DR. The PVD status in patients with diabetes should be evaluated. © Springer 2006.
引用
收藏
页码:15 / 19
页数:4
相关论文
共 50 条
  • [41] Complement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy
    Mandava, Nikhil
    Tirado-Gonzalez, Vanessa
    Geiger, Matthew D.
    Patnaik, Jennifer L.
    Frazer-Abel, Ashley
    Lynch, Anne M.
    Mandava, Naresh
    Palestine, Alan G.
    Holers, V. Michael
    Wagner, Brandie D.
    Sanchez-Santos, Idaira
    Meizner, Daniela
    Quiroz-Mercado, Hugo
    Smith, Jesse M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (11)
  • [42] Incidence and associations of vitreous haemorrhage in proliferative diabetic retinopathy
    Girgis, Shenouda
    Do, Helen Hyun-Jin
    Leong, Belinda
    Liew, Gerald
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 52 (01): : 108 - 110
  • [43] Plasma and Vitreous Metabolomics Profiling of Proliferative Diabetic Retinopathy
    Wang, Hanying
    Li, Shu
    Wang, Chingyi
    Wang, Yihan
    Fang, Junwei
    Liu, Kun
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (02)
  • [44] Cytokine Levels in Human Vitreous in Proliferative Diabetic Retinopathy
    Loporchio, Dean F.
    Tam, Emily K.
    Cho, Jane
    Chung, Jaeyoon
    Jun, Gyungah R.
    Xia, Weiming
    Fiorello, Marissa G.
    Siegel, Nicole H.
    Ness, Steven
    Stein, Thor D.
    Subramanian, Manju L.
    CELLS, 2021, 10 (05)
  • [45] Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy
    Gao, Ben-Bo
    Chen, Xiaohong
    Timothy, Nigel
    Aiello, Lloyd Paul
    Feener, Edward P.
    JOURNAL OF PROTEOME RESEARCH, 2008, 7 (06) : 2516 - 2525
  • [46] WF SS-OCTA for detecting diabetic retinopathy and evaluating the effect of photocoagulation on posterior vitreous detachment
    Gong, Yi
    Hu, Liying
    Wang, Linni
    Shao, Yan
    Li, Xiaorong
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [47] Long-term outcomes of administration of intravitreal triamcinolone acetonide after posterior vitreous detachment during pars plana vitrectomy for proliferative diabetic retinopathy
    Liao, Mengyu
    Huang, Yunli
    Wang, Jiaxing
    Meng, Xiangda
    Liu, Yuanyuan
    Yu, Jinguo
    Yan, Hua
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2023, 107 (04) : 560 - 564
  • [48] Vascular endothelial growth factor (VEGF) concentration in posterior vitreous precortical pocket in proliferative diabetic retinopathy
    Nishizawa, K
    Kadonosono, K
    Itoh, N
    Matsumoto, S
    Shinbo, M
    Ohno, S
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S703 - S703
  • [49] Homocysteine Levels in the Vitreous of Proliferative Diabetic Retinopathy and Rhegmatogenous Retinal Detachment: Its Modulating Role on Lysyl Oxidase
    Coral, Karunakaran
    Angayarkanni, Narayanasamy
    Gomathy, Narayanan
    Bharathselvi, Muthuvel
    Pukhraj, Rishi
    Rupak, Roy
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (08) : 3607 - 3612
  • [50] Preoperative Bevacizumab for Tractional Retinal Detachment in Proliferative Diabetic Retinopathy: A Prospective Randomized Clinical Trial
    Arevalo, J. Fernando
    Lasave, Andres F.
    Kozak, Igor
    Al Rashaed, Saba
    Al Kahtani, Eman
    Maia, Mauricio
    Farah, Michel E.
    Cutolo, Caroline
    Brito, Miguel
    Osorio, Claudia
    Navarro, Patricia
    Wu, Lihteh
    Berrocal, Maria H.
    Morales-Canton, Virgilio
    Serrano, Martin A.
    Graue-Wiechers, Federico
    Sabrosa, Nelson Alexandre
    Alezzandrini, Arturo A.
    Gallego-Pinazo, Roberto
    Liu, T. Y. A.
    Farah, M.
    Penha, F. M.
    Rodrigues, E. B.
    Fromow-Guerra, J.
    -Naranjo, J. L. Guerrero
    Dalma-Weiszhausz, J.
    Velez-Montoya, R.
    Quiroz-Mercado, H.
    Rodriguez, F. J.
    Gomez, F. E.
    Brieke, A. C.
    Goveto, A.
    Berrocal, M. H.
    Cruz-Villegas, V.
    Lozano-Rechy, D.
    Fulda-Graue, E.
    Roca, J. A.
    Hernandez, A.
    Saravia, M. J.
    Schlaen, A.
    Rojas, J.
    Lngolotti, M.
    Avila, M.
    Carla, L.
    Cardillo, J.
    Jorge, R.
    Carpentier, C.
    Verdaguer T, J.
    Verdaguer D, J. I.
    Sepulveda, G.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 207 : 279 - 287